Malignant Neoplasm Clinical Trials in Sioux Falls, South Dakota

4 studies are recruiting for malignant neoplasm in Sioux Falls, South Dakota right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)

   Researchers are looking for new ways to treat children with hepatoblastoma or rhabdomyosarcoma (RMS) that has relapsed or is refractory: * Hepatoblastoma is a common liver cancer in babies and very young children * RMS is a cancer that starts in muscle cells, often in a child's head and neck, bladd…

   Stage

   Phase 1

   Ages

   0 to 17

   Site

   Sanford Children's Hospital ( Site 3015), Sioux Falls, South Dakota

   Locations

   63 in total

   Run by

   Merck Sharp & Dohme LLC

   See if you can join NCT06941272 on ClinicalTrials.gov

2. A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

   Researchers are looking for new ways to treat children with relapsed or refractory solid tumors: * Relapsed means the cancer came back after treatment * Refractory means the cancer did not respond (get smaller or go away) to treatment * Solid tumors are cancers mostly in body organs and tissues, no…

   Stage

   Phase 1

   Ages

   0 to 17

   Site

   Sanford Children's Hospital ( Site 4015), Sioux Falls, South Dakota

   Locations

   26 in total

   Run by

   Merck Sharp & Dohme LLC

   See if you can join NCT07630974 on ClinicalTrials.gov

3. KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)

   Researchers want to learn if using a study medicine called MK-1084 can help treat Non-Small Cell Lung Cancer (NSCLC). MK-1084 is a type of treatment called targeted therapy for the Kirsten rat sarcoma viral oncogene homolog (KRAS) G12C gene change. The goal of this study is to learn about the safet…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Sanford Cancer Center Oncology Clinic ( Site 0038), Sioux Falls, South Dakota

   Locations

   39 in total

   Run by

   Merck Sharp & Dohme LLC

   See if you can join NCT07252739 on ClinicalTrials.gov

4. Project: Every Child for Younger Patients With Cancer

   This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care.

   Stage

   Not phased

   Ages

   Up to 25

   Site

   Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota

   Locations

   279 in total

   Run by

   Children's Oncology Group

   See if you can join NCT02402244 on ClinicalTrials.gov